These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12359033)

  • 1. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.
    Kwiatkowski CF; Fortuin Corsi K; Booth RE
    Addiction; 2002 Oct; 97(10):1289-94. PubMed ID: 12359033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported hepatitis C virus antibody status and risk behavior in young injectors.
    Hagan H; Campbell J; Thiede H; Strathdee S; Ouellet L; Kapadia F; Hudson S; Garfein RS
    Public Health Rep; 2006; 121(6):710-9. PubMed ID: 17278406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.
    Hahn JA; Evans JL; Davidson PJ; Lum PJ; Page K
    Addiction; 2010 Jul; 105(7):1254-64. PubMed ID: 20491725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness.
    Korthuis PT; Feaster DJ; Gomez ZL; Das M; Tross S; Wiest K; Douaihy A; Mandler RN; Sorensen JL; Colfax G; McCarty D; Cohen SE; Penn PE; Lape D; Metsch LR
    Addict Behav; 2012 Apr; 37(4):552-5. PubMed ID: 22209655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal.
    Loewinger G; Sharma B; Karki DK; Khatiwoda P; Kainee S; Poudel KC
    Int J Drug Policy; 2016 Jul; 33():75-82. PubMed ID: 27318773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP; Barry J; Keenan E
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden.
    Norden L; Saxon L; Kåberg M; Käll K; Franck J; Lidman C
    Scand J Infect Dis; 2009; 41(10):727-34. PubMed ID: 19688640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV status knowledge and risk behaviours amongst intravenous drug users.
    Vidal-Trécan G; Coste J; Varescon-Pousson I; Christoforov B; Boissonnas A
    Eur J Epidemiol; 2000 May; 16(5):439-45. PubMed ID: 10997831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico.
    Reyes JC; Colón HM; Robles RR; Rios E; Matos TD; Negrón J; Marrero CA; Calderón JM; Shepard E
    J Urban Health; 2006 Nov; 83(6):1105-13. PubMed ID: 17075726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injecting drug users' understanding of hepatitis C.
    O'Brien S; Day C; Black E; Dolan K
    Addict Behav; 2008 Dec; 33(12):1602-5. PubMed ID: 18762384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
    Fuller CM; Ompad DC; Galea S; Wu Y; Koblin B; Vlahov D
    J Urban Health; 2004 Mar; 81(1):20-4. PubMed ID: 15047780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999.
    Thorpe LE; Ouellet LJ; Levy JR; Williams IT; Monterroso ER
    J Infect Dis; 2000 Dec; 182(6):1588-94. PubMed ID: 11069228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distributive sharing among HIV-HCV co-infected injecting drug users: the preventive role of trust in one's physician.
    Jauffret-Roustide M; Cohen J; Poisot-Martin I; Spire B; Gossop M; Carrieri MP;
    AIDS Care; 2012; 24(2):232-8. PubMed ID: 21777078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
    van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
    Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland.
    Ompad DC; Fuller CM; Vlahov D; Thomas D; Strathdee SA
    Clin Infect Dis; 2002 Oct; 35(7):783-8. PubMed ID: 12228813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.
    Spelman T; Morris MD; Zang G; Rice T; Page K; Maher L; Lloyd A; Grebely J; Dore GJ; Kim AY; Shoukry NH; Hellard M; Bruneau J;
    J Epidemiol Community Health; 2015 Aug; 69(8):745-52. PubMed ID: 25814695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.
    Buchanan D; Tooze JA; Shaw S; Kinzly M; Heimer R; Singer M
    Drug Alcohol Depend; 2006 Feb; 81(3):221-9. PubMed ID: 16171952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.
    Cox J; Morissette C; De P; Tremblay C; Allard R; Graves L; Stephenson R; Roy E
    Subst Use Misuse; 2009; 44(4):548-68. PubMed ID: 19242863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users.
    Cox J; De P; Morissette C; Tremblay C; Stephenson R; Allard R; Graves L; Roy E
    Soc Sci Med; 2008 Jan; 66(2):211-20. PubMed ID: 17920741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.